A
3.76
0.18 (5.03%)
| Penutupan Terdahulu | 3.58 |
| Buka | 3.62 |
| Jumlah Dagangan | 52,471 |
| Purata Dagangan (3B) | 2,175,669 |
| Modal Pasaran | 92,288,840 |
| Harga / Jualan (P/S) | 8.11 |
| Harga / Buku (P/B) | 0.680 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 Aug 2025 |
| EPS Cair (TTM) | -6.04 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -100.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.29% |
| Nisbah Semasa (MRQ) | 13.93 |
| Aliran Tunai Operasi (OCF TTM) | -59.79 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -36.41 M |
| Pulangan Atas Aset (ROA TTM) | -33.29% |
| Pulangan Atas Ekuiti (ROE TTM) | -68.14% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Artiva Biotherapeutics, Inc. | Menaik | Menurun |
AISkor Stockmoo
-1.1
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -3.0 |
| Purata | -1.13 |
|
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 19.99% |
| % Dimiliki oleh Institusi | 89.73% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Venbio Partners Llc | 30 Sep 2025 | 1,148,975 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 23.00 (Wedbush, 511.70%) | Beli |
| Median | 18.00 (378.72%) | |
| Rendah | 15.00 (HC Wainwright & Co., 298.94%) | Beli |
| Purata | 18.67 (396.54%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 5.33 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 12 Nov 2025 | 15.00 (298.94%) | Beli | 3.98 |
| Needham | 17 Oct 2025 | 18.00 (378.72%) | Beli | 6.01 |
| Wedbush | 17 Oct 2025 | 23.00 (511.70%) | Beli | 6.01 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |